Histogen   Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2007)
Status: Defunct (2023)

Organization Overview

First Clinical Trial
2011
NCT01501617
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Histogen

Active Ingredients

Drugs in Phase 2 Trials (5)

Key: Histogen (1) Acquired (4)

cts-1027 (4 trials)

emricasan (17 trials)

hair stimulating complex (2 trials)

interferon alpha-2b (Intron-A) (2 trials)

ribavirin (virazole) (3 trials)

Drugs in Phase 1 Trials (2)

hst 001 (1 trial)

hst003 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 1)

Alopecia Areata (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 25
  • # of Trial APIs: 7